Search results
Results from the WOW.Com Content Network
Here are some of the current FDA-approved MAOIs for treating depression: ... Pregnancy. Some antidepressants, including MAOIs, may be unsafe for women who are pregnant or breastfeeding. If your ...
Federal health officials have approved the first pill specifically intended to treat severe depression after childbirth, a condition that affects thousands of new mothers in the U.S. each year.
The US Food and Drug Administration has approved the medication zuranolone for the treatment of major depressive disorder and severe postpartum depression – making it the first FDA-approved oral ...
It was approved for medical use in the United States in July 2015. [ 16 ] [ 17 ] A generic version was approved in August 2022. [ 18 ] Brexpiprazole is the first treatment approved by the US Food and Drug Administration (FDA) for agitation associated with dementia due to Alzheimer's disease.
Use during pregnancy is of unclear safety. [13] [14] Lurasidone was first approved for medical use in the United States in 2010. [2] In 2013, it was approved in Canada and by the U.S. Food and Drug Administration (FDA) to treat bipolar depression, either as monotherapy or adjunctively with lithium or valproate.
This is a complete list of clinically approved prescription antidepressants throughout the world, as well as clinically approved prescription drugs used to augment antidepressants or mood stabilizers, by pharmacological and/or structural classification.
The Food and Drug Administration (FDA) has approved the first pill to treat postpartum depression (PPD), the agency announced Friday. Zurzuvae is the market’s first pill medication for the ...
Zuranolone, sold under the brand name Zurzuvae, is a medication used for the treatment of postpartum depression. [5] [6] It is taken by mouth.[5]The most common side effects include drowsiness, dizziness, diarrhea, fatigue, nasopharyngitis, and urinary tract infection.